State Street’s VistaGen Therapeutics VTGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $194K | Hold |
96,858
| – | – | ﹤0.01% | 3845 |
|
|
2025
Q1 | $242K | Hold |
96,858
| – | – | ﹤0.01% | 3779 |
|
|
2024
Q4 | $286K | Buy |
96,858
+8,150
| +9% | +$24K | ﹤0.01% | 3766 |
|
|
2024
Q3 | $267K | Hold |
88,708
| – | – | ﹤0.01% | 3756 |
|
|
2024
Q2 | $309K | Buy |
88,708
+5,000
| +6% | +$17.4K | ﹤0.01% | 3690 |
|
|
2024
Q1 | $442K | Buy |
83,708
+34,200
| +69% | +$181K | ﹤0.01% | 3678 |
|
|
2023
Q4 | $254K | Buy |
49,508
+24,044
| +94% | +$124K | ﹤0.01% | 3838 |
|
|
2023
Q3 | $133K | Hold |
25,464
| – | – | ﹤0.01% | 4040 |
|
|
2023
Q2 | $47.6K | Sell |
25,464
-188,937
| -88% | -$353K | ﹤0.01% | 4430 |
|
|
2023
Q1 | $802K | Buy |
214,401
+8,975
| +4% | +$33.6K | ﹤0.01% | 3600 |
|
|
2022
Q4 | $635K | Buy |
205,426
+17,690
| +9% | +$54.7K | ﹤0.01% | 3678 |
|
|
2022
Q3 | $857K | Buy |
187,736
+57,889
| +45% | +$264K | ﹤0.01% | 3627 |
|
|
2022
Q2 | $3.43M | Buy |
129,847
+9,519
| +8% | +$251K | ﹤0.01% | 3280 |
|
|
2022
Q1 | $4.48M | Sell |
120,328
-166,346
| -58% | -$6.19M | ﹤0.01% | 3236 |
|
|
2021
Q4 | $16.8M | Buy |
286,674
+24,836
| +9% | +$1.45M | ﹤0.01% | 2594 |
|
|
2021
Q3 | $21.5M | Buy |
261,838
+159,851
| +157% | +$13.1M | ﹤0.01% | 2433 |
|
|
2021
Q2 | $9.64M | Buy |
+101,987
| New | +$9.64M | ﹤0.01% | 2938 |
|